Related references
Note: Only part of the references are listed.Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients
Pakpoom Phoompoung et al.
TRANSPLANTATION (2020)
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance
Jocelyne Piret et al.
ANTIVIRAL RESEARCH (2019)
Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
Raymund R. Razonable et al.
CLINICAL TRANSPLANTATION (2019)
Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
Susanne Jung et al.
BMC INFECTIOUS DISEASES (2019)
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Per Ljungman et al.
LANCET INFECTIOUS DISEASES (2019)
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Guy El Helou et al.
INFECTION AND DRUG RESISTANCE (2019)
In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products
Takashi E. Komatsu et al.
ANTIVIRAL RESEARCH (2019)
In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
Jochen J. Frietsch et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2019)
Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients
Arnaud G. L'Huillier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection
Lauren Cherrier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
The human cytomegalovirus terminase complex as an antiviral target: a close-up view
G. Ligat et al.
FEMS MICROBIOLOGY REVIEWS (2018)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance
Sunwen Chou
ANTIVIRAL RESEARCH (2017)
Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)
Peter Lischka et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Impact of glycoprotein B genotype and naturally occurring ORF UL56 polymorphisms upon susceptibility of clinical human cytomegalovirus isolates to letermovir
Peter Lischka et al.
ANTIVIRAL RESEARCH (2016)
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Pierre Teira et al.
BLOOD (2016)
Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance
Sunwen Chou
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir
Thomas Goldner et al.
ANTIVIRAL RESEARCH (2015)
Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization
Hongdo Do et al.
CLINICAL CHEMISTRY (2015)
The pathogenesis of human cytomegalovirus
Paul Griffiths et al.
JOURNAL OF PATHOLOGY (2015)
Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants Selected In Vitro after Letermovir (AIC246) Exposure
Thomas Goldner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Roy F. Chemaly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Virologic Suppression Measured by a Cytomegalovirus (CMV) DNA Test Calibrated to the World Health Organization International Standard Is Predictive of CMV Disease Resolution in Transplant Recipients
Raymund R. Razonable et al.
CLINICAL INFECTIOUS DISEASES (2013)
Quality scores and SNP detection in sequencing-by-synthesis systems
William Brockman et al.
GENOME RESEARCH (2008)
Improved DNA sequencing quality and efficiency using an optimized fast cycle sequencing protocol
Adam R. Platt et al.
BIOTECHNIQUES (2007)
Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR
F Griscelli et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
